NCT07319039Toboroz
Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. jan. 8.
Rövid összefoglaló (regiszter, angolul)
Dyspnea that persists despite optimal pathophysiological treatment is defined as persistent dyspnea. Currently all brain functional magnetic resonance imaging (fMRI) studies conducted to evaluate breathlessness have done so using healthy volunteers or have concentrated on acute breathlessness. Little is known about chronic breathlessness patterns and their modulation by different triggers. Furthermore, it is currently assumed in the palliative care literature that patients suffering from different advanced and progressive diseases such as cancer, heart failure (HF) or chronic obstructive pulmonary disease (COPD) have the same triggers, perceptions and neurological pathways and thus require the same treatments/interventions (i.e. opioids as first line symptomatic pharmacologic treatment). However, it is now known that patients belonging to different disease groups do not necessarily benefit from opioids. Aim of the study To assess the feasibility of identifying dyspnea patterns in different life-limiting conditions and to evaluate the effect of immersive virtual reality (IVR) on dyspnea using patient-reported-outcomes (PROMs). Study procedure: Patients with advanced chronic diseases such as cancer, COPD or HF suffering from dyspnea will undergo a brain fMRI in combination with an IVR intervention. The fMRI data will be reviewed to identify different patterns of dyspnea and the effect of IVR on dyspnea will be assessed through PROMs. Patients will be asked about the perceived burden of the study.
- Állapot (regiszter)
- Toboroz
- Vizsgálattípus
- Megfigyeléses
- Résztvevők száma
- 16 (tervezett)
- Első benyújtás
- 2025. máj. 26.
- Kezdés
- 2025. aug. 26.
- Elsődleges befejezés
- 2027. márc. 1.
- Fő szponzor
- University Hospital, Geneva
- NCT-szám
- NCT07319039
Mit vállalsz
- Vizsgálat típusa: Megfigyeléses
- Tervezett résztvevők: 16
- 2025. aug. 26. és az elsődleges befejezés (2027. márc. 1.) között
- 1 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Más betegség
- Diagnosed psychiatric illness (severe depression, severe anxiety, psychosis, other) or antipsychotic treatment deemed a contraindication for fMRI based on physician judgement
- Neurological disorders according to neurological assessment, including diagnosed dementia (frontotemporal dementia, Alzheimer's disease, etc.), brain pathology (tumor, stroke, Parkinson's disease, etc.), or epilepsy
- Contraindication to IVR (migraines, photosensitive epilepsy, vertigo)
Egyéb
- Breathlessness at rest ≥ 8 on the NRS (numeric rating scale 0 to 10)
- Contraindication to fMRI
- Inability to lie flat (supine position)
- Presence of claustrophobia, acrophobia, photophobia, severe hearing loss, and/or severe visual deficit
Kiket keres a vizsgálat
- Age ≥ 18 years and
- Followed by the outpatient palliative care clinic of the Geneva University Hospitals, Switzerland (HUG) and
- Breathlessness at rest > 2 and < 8 on the NRS (numeric rating scale 0 to 10) and
- Persistent breathlessness (persistent dyspnea for > 3 weeks despite adequate and maximal medication according to the pathology) and
- In a stable clinical condition, i.e., without an episode of acute cardiac, respiratory, and/or neurological failure leading to hospitalization in the previous 4 weeks and
- Diagnosis of either HF stage NYHA III-IV, or COPD with dyspnea on the modified MRC scale grade 3-4, or oncological disease with primary or secondary pulmonary involvement
- Age ≥ 18 years and
- No respiratory symptoms: dyspnea, cough, wheezing and
- No known pulmonary, cardiac, or oncological disease and
- Smoking status < 10 pack-years and
- No contraindication to fMRI (Appendix 3) and
- Ability to lie flat (supine position) and
- No diagnosed psychiatric illness (severe depression, severe anxiety, psychosis, other) or antipsychotic treatment deemed a contraindication for fMRI based on physician judgement and
- No neurological disorders according to neurological assessment, including diagnosed dementia (frontotemporal dementia, Alzheimer's disease, etc.), brain pathology (tumor, stroke, Parkinson's disease, etc.), or epilepsy and
- No claustrophobia, acrophobia, photophobia, severe hearing loss, and/or severe visual deficit and
- No contraindication to IVR (migraines, photosensitive epilepsy, vertigo)
Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket is fogad
Helyszínek (1)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Geneva University Hospitals | Geneva | Svájc | Toboroz |
Kapcsolódó publikációk
- Dyspnoea patterns in patients with advanced diseases: a functional MRI feasibility study protocol.BMJ Open · 2026 · PMID 41692519
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.